Toxicity of psychotropic drugs in patients with COVID-19: A systematic review
Open Access
- 18 February 2021
- journal article
- review article
- Published by Elsevier BV in General Hospital Psychiatry
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Return of the Coronavirus: 2019-nCoVViruses, 2020
- Cofilin, an intracellular marker for HIV‐associated CD4 T‐cell motility dysregulation, shed light on the mechanisms of incomplete immune reconstitution in the patients with HIVJournal of Medical Virology, 2019
- Challenging the Negative Perception of Lithium and Optimizing Its Long-Term AdministrationFrontiers in Molecular Neuroscience, 2018
- Valproic acid induced acute liver injury resulting in hepatic encephalopathy- a case report and literature reviewJournal of Community Hospital Internal Medicine Perspectives, 2018
- Elevated clozapine levels associated with infection: A systematic reviewSchizophrenia Research, 2018
- Clinically Significant Psychotropic Drug-Drug Interactions in the Primary Care SettingCurrent Psychiatry Reports, 2012
- Second-Generation Antipsychotic Medications and Risk of Pneumonia in SchizophreniaSchizophrenia Bulletin, 2012
- Valproic acid induced encephalopathy – 19 new cases in Germany from 1994 to 2003 – A side effect associated to VPA-therapy not only in young childrenSeizure, 2006
- Interactions between the cytochrome P450 system and the second-generation antipsychotics.2003
- Serotonin syndrome in HIV-infected individuals receiving antiretroviral therapy and fluoxetineAIDS, 2001